Ōra Medical Clinic: Your Partner in Wellness & Weight Management
Serving California and the state of Washington, Ōra Medical Clinic offers personalized medical weight loss programs, including treatments with Semaglutide and Tirzepatide, to help you achieve your health and wellness goals.
Why Choose Ōra Medical Clinic?
At Ōra Medical Clinic, we believe that true wellness is achieved under expert medical guidance. We are dedicated to helping patients live healthier lives through personalized services like medical weight loss, all carefully supervised by our qualified physicians.
Advanced Weight Loss Options
Our advanced weight loss medications, supervised by physicians, target hormones like GLP-1 and GIP to enhance appetite control and metabolic health. These treatments are tailored to your needs, ensuring safe and effective weight management.
Physician-supervised GLP-1 & GIP treatments for real results
Customized plans to curb cravings and boost metabolism
Safe, effective, and tailored to your unique body chemistry
Our Simple 3-Step Process
We make accessing personalized, physician-supervised care straightforward. Understand the simple steps involved in starting your journey to better health with Ōra Medical Clinic.
Discover Your Path to Wellness
Schedule your consultation today and discover how our physician-supervised programs can help you achieve your health and wellness goals.
Significant Outcomes: By the Numbers
Data from major studies highlights the success rates and additional health benefits associated with these advanced medical weight loss options.
Significant Weight Loss
Clinical trials show GLP-1 therapies help patients achieve an average weight loss exceeding 15% of their body weight.
Enhanced Results
Dual-action GIP/GLP-1 therapies have demonstrated even greater average weight loss, often exceeding 20%, in clinical studies.
Major Milestones Achieved
In some studies, a significant portion of patients utilizing specific doses achieved weight loss greater than 25%.
Reduced Cardiovascular Risk
In a major clinical trial (SELECT), Semaglutide reduced the risk of major adverse cardiovascular events (like heart attack or stroke) by 20% in eligible patients with overweight/obesity and existing heart disease.
Applying Medical Breakthroughs in Everyday Clinical Practice
Breakthrough weight loss medications with remarkable ability to may protect the body from within and support healing
WeGovy® / Ozempic®
Active Ingredient: Semaglutide
Semaglutide is a medication originally developed to treat type 2 diabetes, but it's also been approved for weight loss. It works by mimicking the natural GLP-1 (glucagon-like peptide-1) hormone, helping to regulate blood sugar and reduce appetite.
Semaglutide works by mimicking a natural hormone in the body called GLP-1 (glucagon-like peptide-1), which helps control blood sugar by increasing insulin release, slows down digestion which leads to you feeling full longer, and acts on the brain which reduces hunger and cravings.
With diet and exercise, patients lost up to 15% of their body weight and were able to maintain their weight loss while taking Semaglutide for over 2 years.
Affecting >10% - Nausea (most common, especially at the start), vomiting, diarrhea, constipation, abdominal pain or bloating. These usually occur early on and often improve as the body adjusts.
Affecting 1-10% - Fatigue, dizziness (especially with low food or fluid intake), indigestion or reflux, headaches, injection site reaction (mild redness, swelling, or itching).
Individuals with personal or family history of Medullary Thyroid Cancer or MEN2 Syndrome. Individuals who are pregnant, breast feeding, or trying to conceive.
Mounjaro® / Zepbound®
Active Ingredient: Tirzepatide
Tirzepatide is a next-generation injectable medication used to treat type 2 diabetes and obesity. It works by mimicking the natural GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) hormones, enhancing body’s metabolic process which result in weight loss and better type 2 diabetes control.
Tirzepatide is unique because it mimics two natural hormones:
- GLP-1: Reduces appetite, improves insulin response, slows digestion. - GIP: May further reduce appetite and help the body burn fat more effectively.
This dual action leads to powerful effects on weight and blood sugar control.
With diet and exercise, patients lost over 20% of their body weight, have shown significant improvement in blood sugars and improvement in other health issues related to disrupted metabolic function.
Affecting >10% - Nausea (most common, especially at the start), vomiting, diarrhea, constipation, abdominal pain or bloating. These usually occur early on and often improve as the body adjusts.
Affecting 1-10% - Fatigue, dizziness (especially with low food or fluid intake), indigestion or reflux, headaches, injection site reaction (mild redness, swelling, or itching).
Individuals with personal or family history of Medullary Thyroid Cancer or MEN2 Syndrome. Individuals who are pregnant, breast feeding, or trying to conceive.
Understanding Your Weight Loss Options: Insights from Medical Doctors
Understanding the science behind treatments like Semaglutide and Tirzepatide is crucial. These videos provides valuable insights into how these medications work. After watching, if you have questions about how these approaches could fit into your personal health journey, the Ōra Medical Clinic team is here to offer a comprehensive consultation.
Expanding Therapeutic benefits of GLP-1/GIP
Semaglutide and Tirzepatide offer benefits beyond weight loss
Heart Health
Tirzepatide has shown to significantly reduced the risk of cardiovascular death or worsening heart failure events, along with improvements in health related quality of life, functional capacity, and exercise tolerance.
Read StudyLiver Health
Semaglutide helps improve liver health in people with metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease, by reducing inflammation and liver damage.
Read StudyKidney Health
The study showed Semaglutide helped slow the progression of chronic kidney disease (CKD) in diabetic patients. It improves blood sugar control and reduces risk factors like high blood pressure and inflammation, contributing to kidney protection.
Read StudyBrain Health
Semaglutide is associated with a reduced risk of developing Alzheimer's disease in patients with diabetes and may have protective effects against Alzheimer's in people with type 2 diabetes.
Read StudySleep Health
In two large clinical trials, participants who received Tirzepatide experienced a significant reduction in the number of breathing interruptions during sleep, known as the apnea-hypopnea index (AHI), compared to those who received a placebo. Additionally, those on Tirzepatide lost more weight, had lower blood pressure, and reported better sleep quality, suggesting Tirzepatide can be a promising treatment option for individuals struggling with both obesity and sleep apnea.
Read StudyEndocrine Health
Three years of treatment with Tirzepatide in individuals with obesity and prediabetes resulted in substantial and sustained weight reduction and a significantly lower risk of progression to type 2 diabetes compared to those treated with placebo.
Read Study
Introducing Dr. Pardis Poorzand: A Leader in Metabolic Health
Dr. Pardis Poorzand is a board certified Internal Medicine physician with nearly ten years of experience specializing in the understanding, prevention, and treatment of complex chronic diseases, many of which are related to metabolic syndrome (including obesity, high blood pressure, high cholesterol, and diabetes). She takes a holistic approach to care, emphasizing the importance of addressing obesity as a root cause of metabolic issues rather than merely managing its symptoms. Dr. Poorzand is particularly passionate about integrating innovative treatments such as GLP-1 medications with personalized nutrition, physical activity, and lifestyle changes to help patients achieve sustainable, long-term health improvements.
Board Certified in Internal Medicine with nearly a decade of clinical experience.
Specializes in managing obesity and metabolic syndrome by focusing on root causes rather than just downstream consequences.
Utilizes modern treatments, including GLP-1 medications, to support weight management and inspire comprehensive lifestyle improvements.
FAQs
GLP-1 (Glucagon-Like Peptide-1) mimics the action of a naturally occurring peptide called glucagon-like peptide 1. This hormone is produced in the gut in response to food and stimulates the production of both glucagon and insulin to regulate blood sugar levels.
GLP-1s are not recommended for patients with a family history of edullary hyroid arcinoma (MTC) or Multiple Endocrine Neoplasia yndrome type 2 (MEN 2). They are also contraindicated in patients who are pregnant or breastfeeding.
The most common side effects include nausea, vomiting, diarrhea, and constipation. Patients may experience fatigue or dizziness, particularly if they are not staying well hydrated or are following a severely calorie restricted diet. There is also a risk of low blood sugar, especially in diabetic patients who are taking other blood glucose lowering medications.
Sarcopenia, the loss of muscle mass, can occur with any form of severe calorie restricted diet not just those involving GLP-1 medications. Patients on GLP-1 therapy, especially postmenopausal women, are at increased risk of sarcopenia if their weight loss is not supported by regular exercise and adequate protein intake. This is why it's crucial to have a qualified medical provider monitor your weight loss and guide you through the process.
Contact Ōra Medial Clinic
Fill up the form and our Team will get back to you within 24 hours.